샷다 vs DoseWeek
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
샷다
This app helps users track their GLP-1 injections, monitor weight changes, and record side effects and diet. It offers reminders for injection schedules and a community forum for users to share information.
- Injection scheduling and reminders
- Weight change tracking and goal achievement
- Side effect and condition logging
- Diet and exercise recording
- Calendar view of daily records
- Community forum for users
- Customizable app fonts
Read full descriptionHide full description
샷다는 GLP-1 주사(마운자로, 위고비)를 맞으며 체중을 관리하는 분들을 위한 기록 다이어리입니다. ■ 주사 기록과 투여일 알림 언제, 어디에, 몇 mg을 맞았는지 기록하면 다음 투여 예정일을 계산해 알림으로 알려드려요. 투여 주기는 기본 7일에서 자유롭게 조정할 수 있어 테이퍼링(감량 유지) 시기처럼 간격이 늘어나도 계속 정확하게 관리됩니다. 마운자로는 펜 사용 순서(몇 펜째)까지 함께 관리됩니다. ■ 체중 변화 한눈에 기록할 때마다 직전 대비 증감이 표시되고, 시작 체중에서 목표까지 얼마나 왔는지 달성률로 보여드려요. ■ 부작용과 컨디션 기록 메스꺼움, 변비, 피로감 같은 부작용을 약물별 항목으로 남기고 심각도를 함께 기록할 수 있어요. 몸상태·정서·식욕조절도 매일 간단히 체크할 수 있습니다. ■ 식단과 운동 음식을 검색해 칼로리와 탄단지를 기록하고, 자주 먹는 조합은 세트로 저장해 다음부터 한 번에 담을 수 있어요. GLP-1은 식욕을 크게 눌러 단백질이 모자라기 쉬운데, 체중에 맞춘 하루 단백질 목표를 함께 보여드립니다. ■ 캘린더로 돌아보기 한 달치 기록이 달력에 쌓입니다. 날짜를 누르면 그날 남긴 모든 기록을 한 카드에서 확인하고 바로 수정할 수 있어요. ■ 커뮤니티 같은 약을 쓰는 사람들과 정보를 나누고 궁금한 점을 물어볼 수 있어요. 신고·차단 기능으로 안전하게 운영됩니다. ■ 내 취향대로 귀여운 손글씨부터 담백한 고딕까지, 14가지 글꼴 중에 골라 앱 전체에 적용할 수 있어요. [중요 안내] 샷다는 이용자가 스스로 건강 정보를 기록하고 돌아보도록 돕는 도구이며, 「의료기기법」상 의료기기가 아닙니다. 앱이 제공하는 통계·그래프·알림은 참고용 정보일 뿐 의사·약사의 진단, 처방, 상담을 대체하지 않습니다. 의약품의 사용 여부와 용법·용량은 반드시 의료 전문가와 상의해 결정하시고, 투여 중 이상이 느껴지면 즉시 의료기관을 방문해주세요.
DoseWeek
This app is a private, manual log for tracking injection therapy schedules, doses taken, side effects, and body changes. It offers customizable cycle lengths and intervals, with all data stored locally and encrypted for user control. Optional on-device AI features assist with data entry and visit preparation.
- Track injection schedules
- Log doses taken and locations
- Record side effects and body changes
- Customizable cycle lengths (1-90 days)
- Flexible dosing intervals
- Private, on-device data storage
- Encrypted backups controlled by user
Read full descriptionHide full description
Keep your injection schedule and records in one place, including GLP-1 medicines such as Mounjaro (tirzepatide) and Wegovy or Ozempic (semaglutide), plus weight and meals. Keep records locally without signing in. Free includes: repeat intervals or up to 60 dates in a year; confirmed injections, sites and symptoms; supplies; weight and body charts (weight: last month); meals and favorites; adding past injections at once; CSV/TSV import; CSV/PDF visit reports; widgets; app lock; encrypted file backup and restore. Review imported rows and drafts before saving. Optional calendar sync sends only titles and times, never medicine, dose, site or notes. Optional Apple Health import is read-only and never writes to Apple Health. File backups use AES-256-GCM and a recovery code. Food labels are read on the device, and Apple Intelligence drafts are created on the device where supported. Manual entry is always available. Optional monthly or annual Plus removes ads and adds weekly reports and milestones, side-effect patterns and weight goal and trend estimates (last 3 months). Plus also includes end-to-end encrypted sync across devices. Optional monthly or annual Pro includes everything in Plus, a visit report PDF with charts, comparisons and a rolling 12-month view, supply forecasts and refill reminders, themes and Today presets, meal templates, full weight history and the AI record assistant: up to 150 requests a month for a weekly summary, general meal ideas and help using the app. It needs sign-in and separate consent, asks before each send and never gives medical advice; answers may be wrong. What you confirm is sent to Gemini on Google Cloud Vertex AI (Global): the processing country can change with each request, and this content is outside end-to-end encryption. For first-time subscribers, Plus has 1 month free and Pro has 7 days free (up to 20 AI requests) only when the store confirms eligibility and the offer. The chosen plan renews automatically at the shown store price; cancel any time in the store. Any required paid-conversion consent is obtained first. Sign in with Apple or Google is optional. Sync requires separate health-data consent and device encryption; the server cannot read health records or the recovery code. On a new device, enter the code and review the merge. You can withdraw sync consent at any time. Account deletion does not cancel store billing. Free shows non-personalized ads, never while recording; DoseWeek doesn't use your device's advertising identifier. Optional rewarded ads give up to 2 days without ads. Analytics and overseas transfer require separate optional consent, independent of sign-in, sync and ads. Refuse or withdraw in Settings and keep core features. Google analytics may receive usage, identifiers, device data, IP address and approximate city, never health records or recovery keys. Estimated amount remaining in the body (mg) is for reference only, not medical advice. Goal dates and side-effect patterns use recorded data and appear only with enough records; no dose or timing advice, cause conclusions or safety predictions. DoseWeek is not a medical device. It does not diagnose, treat, cure or prevent disease. Consult a qualified healthcare professional for medication, dose, timing or missed-dose decisions. Terms of Use: https://doseweek-legal.wonyoungchoi.dev/terms/ Privacy Policy: https://doseweek-legal.wonyoungchoi.dev/privacy/
Screenshots
Verdict
The clearest difference is monetization model: 샷다 at free against DoseWeek's paid. 샷다 also leads on ads (none vs shown) and iOS requirement (15.0 vs 26.0). On price, review sentiment, update cadence and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
샷다 ships an update every 3 days, DoseWeek every 2 days. The most recent releases landed on October 11, 2026 and October 8, 2026 respectively.
| Parameter | 샷다 | DoseWeek |
|---|---|---|
| Price | Free | Free |
| Positive reviews | 100.0% of reviews | 100.0% of reviews |
| Update frequency | Every 3 days | Every 2 days — better |
| Ads | No — better | Yes |
| In-app purchases | No | No |
| Monetization | Free — better | Paid |
| Devices | iPhone, iPod | iPhone, iPad |
| Requires iOS | 15.0 — better | 26.0 |
| Further details — not scored | ||
| Size | 2 MB | 63 MB |
| Age rating | 17+ | 17+ |
| Developer | Jaekyoung Cho | Wonyoung Choi |
Customer experience
샷다
DoseWeek
In-app purchases
샷다
No in-app purchases
DoseWeek
No in-app purchases








